Tuesday, April 22, 2014

Valeant, Ackman offer to buy Botox maker Allergan for $47 bln

Canadian company Valeant Pharmaceuticals International Inc. and activist investor Bill Ackman moved forward with their plans to acquire Botox maker Allergan Inc., offering shareholders about $46 billion and touching off what could be a contentious fight.





** AGN daily **

** AGN weekly **

No comments:

Post a Comment